Degradation kinetics of fluorouracil-acetic-acid-dextran conjugate in aqueous solution

Drug Development and Industrial Pharmacy

Volumn 32, Issue 6, 2006, Pages 757-763

  Hao, A J ^a   Deng, Y J ^a   Li, T F ^a   Suo, X B ^a   Cao, Y H ^b   Hao, Y L ^a   Zhang, Y ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Changli Hospital of Traditional Chinese Medicine   (China)

Author keywords

Chemical stability; Degradation kinetics; Dextran; Fluorouracil

Indexed keywords

ACETIC ACID; BUFFER; DEXTRAN DERIVATIVE; FLUOROURACIL; SODIUM CHLORIDE;

ACIDITY; ALKALINITY; AQUEOUS SOLUTION; ARTICLE; CALCULATION; CATALYSIS; CONJUGATE; DEGRADATION KINETICS; ENERGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; PH; REACTION ANALYSIS; TEMPERATURE SENSITIVITY;

ANTINEOPLASTIC AGENTS; BUFFERS; DEXTRANS; DRUG STABILITY; FLUOROURACIL; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KINETICS; MODELS, CHEMICAL; SODIUM CHLORIDE; SOLUTIONS; TEMPERATURE; WATER;

EID: 33746841345     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600683436     Document Type: Article

References (19)

1. Chourasia, M. K., & Jain, S. K. (2004). Polysaccharides for colon targeted drug delivery. Drug Delivery, 11, 129-48.
2. Chung, S. M., Yoon, E. J., Kim, S. H., Lee, M. G., Lee, H., Park, M. K., & Kim C. K. (1991). Pharmacokinetics of 5-fluorouracil after intravenous infusion of 5-fluorouracil-acetic acid-human serum albumin conjugates to rabbits. International Journal of Pharmaceutics, 68, 61-68.
3. Hamed, H. S., & Hamer, W. J. (1933). The ionization constant of water in potassium chloride solutions from electromotive forces of cells without liquid junction. Journal of the American Chemical Society, 55, 2194-2206.
4. Hao, A. J., Deng, Y. J., Suo X. B., & Cao, Y. H. (2006). Synthesis and characteristics of the fluorouracil-dextarn conjugates. Die Pharmzie (Accepted).
5. Hoste, K., Winne, K. D., & Schacht. E. (2004). Polymeric prodrugs. International Journal of Pharmaceutics, 277, 119-131.
6. Jung, Y. J., Lee, J. S., Kim, H. H., Kim, Y. K., & Kim, Y. M. (1998) Synthesis and properties of dextran-5-amino salicylic acid ester as a potential colon-specific prodrug of 5-amino salicylic acid. Archives Pharmaceutical Research. 21, 179-186.
7. Kang, N. I., Lee, S. M., Maeda, M., Ha, C. S., & Cho, W. J. (2002). Synthesis, antitumour and DNA replication activities of polymers containing vinyl-(5-fluorouracil)-ethanoate. Polymer International, 51, 443-449.
8. Larsen, C. (1989a). Macromolecular prodrugs. XIII. Determination of the ionization constant of dextran by potentiometric titration and from kinetic analysis of the hydrolysis of dextran indomethacin ester conjugates. International Journal of Pharmaceutics, 52, 55-61.
9. Larsen, C. (1989b). Macromolecular prodrugs. XII. Kinetics of release of naproxen from various polysaccharide ester prodrugs in neutral and alkaline solution. International Journal of Pharmaceutics, 51 (3), 233-240.
10. Larsen, C., Harboe, E., Johansen, M., & Olesen, H. P. (1989) Macromolecular prodrugs. XVI. Colon-targeted delivery - comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract. Pharmaceutical Research, 6(12), 995-9.
11. Lee, J. S., Jung, Y. J., Doh, M. J., & Kim, Y. M. (2001). Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Drug Development and Industrial Pharmacy. 27 (4), 331-336.
12. Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003). 5-Fluorouracil: mechanisms of action and clinical strategies. Nature reviews. Cancer, 3, 330-338.
13. McLeod, A. D., Friend, D. R., & Tozer, T. N. (1993). Synthesis and chemical stability of glucocorticoid- dextran esters: potential prodrugs for colon-specific delivery, International Journal of Pharmaceutics. International Journal of Pharmaceutics, 92, 105-114.
14. Mdró, M., & Pató, J. (1990). Polymeric prodrugs, 8. Synthesis and hydrolytic behaviour of dextran-bound anticancer agents. Die Makromolekulare Chemie, 191(5), 1051-1056.
15. Mehvar, R. (2000). Dextrans for targeted and sustained delivery of therapeutic and imaging agents. Journal of controlled release, 69, 1-25.
16. Nassim, M. A., Shirazi, F. H., Cripps, C. M., Ghan, S. V., Molepo, M. A., Obrocea, M., Redmond, D., Bates, S., Fry, D., Stewart, D. J., & Goel, R. (2002). An HPLC method for the measurement of 5-fluorouracil in human plasma with a low detection limit and a high extraction yield. International journal of molecular medicine, 10, 513-516.
17. Ouchi, T. Banba, T., Fujimoto, M., & Hamamoto, S. (1989). Synthesis and antitumor activity of chitosan carrying 5-fluorouracils. Die Makromolekulare Chemie. 190 (8), 1817-25.
18. Pang, Y. N., Zhang, Y., & Zhang, Z. R. (2002). Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting. World Journal of Gastroenterology, 8(5), 913-917.
19. Tada, M. (1975). Antineoplastic agents. The preparation of 5-fluorouracil-l-acetic acid derivative. Bulletin of the Chemical Society of Japan, 48, 3427-3428.